AI Denial Nightmare Hits Medicare

Wooden blocks spelling out 'MEDICARE' on a dark background — HUGE MEDICARE SHOCKER

President Trump’s Medicare pilot to use AI for approving or denying care is reigniting fierce debate about government overreach, patient rights, and the peril of automated healthcare rationing.

Story Snapshot

Medicare will begin piloting AI-powered prior authorization in 2026, mirroring controversial private insurer practices.
AI systems have been accused of systematically denying necessary care, raising alarms among physicians and patients.
Legal challenges against United Healthcare and Humana highlight risks of automation without proper oversight.
Advocacy groups warn of increased barriers for elderly and chronically ill Americans.

AI Automation in Healthcare: From Private Insurers to Medicare

Major private health insurers, including United Healthcare and Humana, have adopted artificial intelligence algorithms to streamline prior authorization, automating the approval or denial of medical treatments.

These systems, designed to cut costs and increase efficiency, have triggered lawsuits and widespread concern after reports surfaced of systematic care denials, sometimes overriding doctors’ recommendations.

Now, the federal government is piloting similar AI-driven authorization programs in Medicare, beginning January 2026 in select states, marking a dramatic shift in how public healthcare decisions are made.

Physicians and Patients Sound the Alarm on Denials

Physicians and patient advocacy groups are raising concerns that AI-driven prior authorization is eroding timely access to necessary care, especially for vulnerable populations such as the elderly and chronically ill.

Surveys from the American Medical Association reveal that 61% of doctors believe these systems are increasing denials and leading to patient harm. Providers face growing administrative burdens, while patients grapple with delays and uncertainty.

Despite claims from insurers of “human oversight,” litigation and expert testimony argue that automation is now driving batch denials with minimal review, undermining trust and accountability in the healthcare system.

Legal and Regulatory Challenges Intensify

Legal scrutiny of AI in insurance is mounting. Class-action lawsuits against United Healthcare and Humana allege wrongful denials and lack of transparency in decision-making.

Regulators and lawmakers are now under pressure to ensure that Medicare’s AI pilot program does not repeat the private sector’s mistakes.

The Centers for Medicare & Medicaid Services, charged with overseeing the pilot, faces growing calls for robust safeguards, transparent accountability, and evidence-based standards to protect patient rights.

Policy experts warn that without strict oversight, the normalization of automated coverage decisions could lead to widespread harm and further erode public trust.

Conservative Concerns: Government Overreach and Threats to Patient Rights

For conservative Americans, the expansion of AI-driven prior authorization into Medicare raises alarm about government overreach and the erosion of individual liberty in healthcare.

The pilot program’s potential to automate mass denials not only threatens patient choice but also risks undermining core values of self-determination and limited government.

Advocacy groups argue that medical decisions should remain in the hands of clinicians, not algorithms.

With mounting legal and public opposition, the outcome of this pilot could shape the future of healthcare—either restoring common sense and constitutional protections, or further entrenching bureaucratic control over life-and-death decisions.

Private health insurers use AI to approve or deny care. Soon Medicare will, too. A pilot program testing the use of artificial intelligence to expand prior authorization decisions in Medicare has providers, politicians and researchers asking questions. https://t.co/bY9dFSAedj pic.twitter.com/sO42MyARLt

— Evan Kirstel #B2B #TechFluencer (@EvanKirstel) September 25, 2025

Industry Response and Future Outlook

Insurers and AI vendors defend the new systems as necessary for controlling costs and reducing waste, promising improvements in oversight and transparency. The insurance trade group AHIP has pledged to reduce the scope of prior authorization and enhance visibility into automated decisions.

Meanwhile, Medicare’s pilot program, set to run through 2031, is still in early planning stages. The debate over AI in healthcare is intensifying, with stakeholders across the spectrum demanding stronger governance and ethical standards.

As legal battles continue and regulatory scrutiny deepens, the outcome will determine whether technology serves patients—or becomes another tool for rationing care and expanding government power.